Graduate School of Pharmaceutical Sciences, Kyoto University.
Biol Pharm Bull. 2020;43(4):576-583. doi: 10.1248/bpb.b19-00831.
Small extracellular vesicles (sEVs), including exosomes as typical example, are cell-derived vesicles comprising lipid bilayer with a diameter approximately 100 nm. sEVs are endogenous delivery vehicles that deliver their contents such as nucleic acids and proteins to recipient cells. Because of their potential nature as endogenous delivery vehicles, therapeutic applications of sEVs as delivery systems of various drugs are expected. To develop sEV-based therapeutics, a variety of challenges should be overcome. In this review, we summarize the current status and future perspectives of therapeutic applications of sEVs. Several pharmaceutical and pharmacokinetic challenges will be discussed.
小细胞外囊泡 (sEVs),包括外泌体作为典型的例子,是由脂质双层组成的直径约 100nm 的细胞衍生囊泡。sEVs 是内源性的递药载体,可将其内容物(如核酸和蛋白质)递送到受体细胞。由于它们作为内源性递药载体的潜在性质,预计 sEVs 将作为各种药物的递药系统得到治疗应用。为了开发基于 sEV 的治疗方法,需要克服多种挑战。在这篇综述中,我们总结了 sEV 的治疗应用的现状和未来展望。我们将讨论几个药物制剂和药代动力学方面的挑战。